Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies, , , , , , , , , and 13 other author(s). EMBO Rep, 22 (5): e52325 (April 2021)Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia-A Cross-Sectional Assessment Providing Preliminary Surveillance Data, , , , , and . Vaccines, 9 (10): 1120 (October 2021)Seroprevalence of Hepatitis E virus in children and adolescents living in urban Bogota: An explorative cross-sectional study, , , , , , , and . Front Public Health, (February 2023)Immune response to SARS-CoV-2 variants of concern in vaccinated individuals, , , , , , , , , and 16 other author(s). Nat Commun, 12 (1): 3109 (May 2021)Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients, , , , , , , , , and 10 other author(s). Front Immunol, (October 2022)Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia, , , , , , , , , and 5 other author(s). Commun Med (Lond), 3 (1): 151 (October 2023)SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition, , , , , , , , , and 32 other author(s). Nat Immunol, 22 (1): 74-85 (September 2021)Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis, , , , , , , , , and 9 other author(s). EBioMedicine, (August 2021)Antibody binding and ACE2 binding inhibition is significantly reduced for both the BA1 and BA2 omicron variants, , , , , , , , , and 31 other author(s). Clin Infect Dis, 76 (3): e240-e249 (2023)Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations, , , , , , , , , and 20 other author(s). Scientific Reports, 12 (1): 19858 (November 2022)